Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715

Mid-range Performer

Check Buy or Sell

959.60 -8.85 (-0.91%)

52W Low on Jun 17, 2022

2.7M NSE+BSE Volume

NSE May 30, 2023 03:31 PM

7

Broker 1Year buys

7 active buys

0

Broker 1Year sells

0 active sells

2

Broker 1Year neutral

2 active holds

Sun Pharmaceutical Industries Ltd. share price forecast

View 29 reports from 11 analysts offering long term price targets for Sun Pharmaceutical Industries Ltd.. Sun Pharmaceutical Industries Ltd. has an average target of 1130.00. The consensus estimate represents an upside of 17.76% from the last price of 959.60.

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	27 May 2023	Sun Pharmaceutical I..	Motilal Oswal Target	959.60	1160.00	969.90 (-1.06%)	20.88	Buy	pdf post cache		Broker Report US/EM/ROW drive earnings for the quarter Motilal Oswal pdf Share on Share on Share on Share on Comment
	27 May 2023	Sun Pharmaceutical I..	ICICI Securities Limited Reco Target	959.60	1160.00	969.90 (-1.06%)	20.88	Buy	pdf post cache		Broker Report Specialty portfolio is amplifying margins ICICI Securities Limited Sun Pharmaceutical’s (Sun) Q4FY23 performance was decent, aided by traction in specialty portfolio, India branded and launch of Revlimid in the US. Specialty business sales contribution had increased to 16.6% in FY23 (14% in FY22) and key assets like Ilumya, Winlevi and Cequa will likely improve the share to 21% by FY25E. pdf Share on Share on Share on Share on Comment
	27 May 2023	Sun Pharmaceutical I..	ICICI Direct Target	959.60	1140.00	969.90 (-1.06%)	18.80	Buy	pdf post cache		Broker Report Sun Pharma ICICI Direct pdf Share on Share on Share on Share on Comment
	01 Feb 2023	Sun Pharmaceutical I..	ICICI Securities Limited Target	959.60	1001.00	1034.50 (-7.24%)	Target met	Hold	pdf post cache		Broker Report In-line performance; valuations fair ICICI Securities Limited Sun Pharmaceutical’s (Sun) Q3FY23 performance was largely in line with our estimates. Consolidated revenue grew 12.9% YoY to Rs111.4bn (I-Sec: Rs110.5bn) driven by US and emerging market sales. EBITDA margin stood at 26.0% (I-Sec: 26.6%). Specialty portfolio grew 10.7% QoQ to US$223mn (ex- milestone income) led by growth in Ilumya and Winlevi. pdf Share on Share on Share on Share on Comment
	01 Feb 2023	Sun Pharmaceutical I..	ICICI Direct Target	959.60	1210.00	1014.90 (-5.45%)	26.09	Buy	pdf post cache		Broker Report Sun Pharma ICICI Direct pdf Share on Share on Share on Share on Comment
	31 Jan 2023	Sun Pharmaceutical I..	Motilal Oswal Target	959.60	1220.00	1034.50 (-7.24%)	27.14	Buy	pdf post cache		Broker Report Specialty sales remains encouraging Motilal Oswal pdf Share on Share on Share on Share on Comment
	19 Jan 2023	Sun Pharmaceutical I..	Motilal Oswal Target	959.60	1200.00	1040.55 (-7.78%)	25.05	Buy	pdf post cache		Broker Report Concert deal paves way to add JAK inhibitors to specialty portfolio Motilal Oswal pdf Share on Share on Share on Share on Comment
	10 Nov 2022	Sun Pharmaceutical I..	Geojit BNP Paribas Reco Target	959.60	1078.00	1013.55 (-5.32%)	12.34	Hold	pdf post cache		Broker Report SUN PHARMA Geojit BNP Paribas pdf Share on Share on Share on Share on Comment
	03 Nov 2022	Sun Pharmaceutical I..	SMC online	959.60		1039.90 (-7.72%)		Results Update	pdf post cache		Broker Report Sun Pharmaceuticals Industries SMC online pdf Share on Share on Share on Share on Comment
	03 Nov 2022	Sun Pharmaceutical I..	KRChoksey Target	959.60	1229.00	1051.95 (-8.78%)	28.07	Buy	pdf post cache		Broker Report Profitability boosted by strong revenues & operating performance KRChoksey In Q2FY23, SUNP reported strong revenue growth of 13.8% YoY (+1.8% QoQ) to INR 109,523 mn. pdf Share on Share on Share on Share on Comment
	02 Nov 2022	Sun Pharmaceutical I..	Motilal Oswal Target	959.60	1240.00	1051.95 (-8.78%)	29.22	Buy	pdf post cache		Broker Report Another quarter of an earnings beat Motilal Oswal pdf Share on Share on Share on Share on Comment
	02 Nov 2022	Sun Pharmaceutical I..	Prabhudas Lilladhar Target	959.60	1175.00	1044.20 (-8.10%)	22.45	Buy	pdf post cache		Broker Report SUN PHARMACEUTICAL I Prabhudas Lilladhar pdf Share on Share on Share on Share on Comment
	02 Nov 2022	Sun Pharmaceutical I..	ICICI Securities Limited Target	959.60	1002.00	1036.60 (-7.43%)	Target met	Hold	pdf post cache		Broker Report Specialty business grows; margins expand ICICI Securities Limited Sun Pharmaceutical’s (Sun) Q2FY23 performance has been better than our estimates. pdf Share on Share on Share on Share on Comment
	02 Nov 2022	Sun Pharmaceutical I..	ICICI Direct Target	959.60	1225.00	1051.95 (-8.78%)	27.66	Buy	pdf post cache		Broker Report Sun Pharma ICICI Direct pdf Share on Share on Share on Share on Comment
	01 Nov 2022	Sun Pharmaceutical I..	Bonanza	959.60	1072.00	1036.60 (-7.43%)	Target met	Buy	pdf post cache		Broker Report STRATEGY: TECHNICAL RESULT PREVIEW Q2 FY23 Bonanza Given that there are good chances of breakout on both the sides but down side is normally remained limited in Sun Pharma historically. pdf Share on Share on Share on Share on Comment
	01 Nov 2022	Sun Pharmaceutical I..	BOB Capital Markets Ltd. Reco	959.60	1100.00	1051.95 (-8.78%)	14.63	Hold	pdf post cache		Broker Report Sun Pharma (HOLD): Strong Q2 but valuations full cut to HOLD BOB Capital Markets Ltd. Brisk Q2 revenue growth at 14% YoY to Rs 110bn backed by ramp-up in global specialty business and healthy India/EM sales pdf Share on Share on Share on Share on Comment
	03 Oct 2022	Sun Pharmaceutical I..	KRChoksey Target	959.60	1114.00	948.65 (1.15%)	16.09	Buy	pdf post cache		Broker Report Ticking all the boxes KRChoksey Bajaj Finance Ltd (BAF) is the lending arm of Bajaj Finserv Ltd. It has a diverse set of product portfolio which is targeted towards meeting the changing consumer preferences. pdf Share on Share on Share on Share on Comment
	05 Aug 2022	Sun Pharmaceutical I..	Edelweiss Target	959.60	916.00	915.95 (4.77%)	Target met	Buy	pdf post cache		Broker Report Pick of the Week - Sun Pharmaceutical Industries Ltd. Edelweiss Sun Pharmaceuticals is the largest Indian Pharma company with an impressive track record of organic and inorganic growth. pdf Share on Share on Share on Share on Comment
	01 Aug 2022	Sun Pharmaceutical I..	SMC online	959.60		897.00 (6.98%)		Results Update	pdf post cache		Broker Report Sun Pharmaceutical Industries SMC online pdf Share on Share on Share on Share on Comment
	31 Jul 2022	Sun Pharmaceutical I..	Prabhudas Lilladhar Target	959.60	1070.00	918.70 (4.45%)	Target met	Buy	pdf post cache		Broker Report SUN PHARMACEUTICAL I Prabhudas Lilladhar pdf Share on Share on Share on Share on Comment
more loading

Advisor Screeners